G1 THERAPEUTICS, INC. Increase (Decrease) in Inventories
G1 THERAPEUTICS, INC. reported Increase (Decrease) in Inventories of $941.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2024-08-08
- G1 THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2024-06-30 was $835.00K, a 1364.91% increase year-over-year.
- G1 THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2024-03-31 was $106.00K.
- G1 THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2023-12-31 was -$1.05M, a 147.06% decline year-over-year.
- G1 THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2023-09-30 was -$2.11M.
- G1 THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2023 was -$3.74M, a 129.41% decline from fiscal 2022.
- G1 THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2022 was $12.71M, a 266.12% increase from fiscal 2021.
- G1 THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2021 was $3.47M.
- G1 THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2024-06-30 | $835.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $941.00K 10-Q · filed 2024-08-08 | -$108.00K derived: sum of 3 quarters · filed 2024-08-08 | -$2.22M derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $106.00K 10-Q · filed 2024-05-01 | -$943.00K derived: sum of 2 quarters · filed 2024-05-01 | -$3.05M derived: sum of 3 quarters · filed 2024-05-01 | -$3.00M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$3.16M derived: sum of 2 quarters · filed 2024-02-28 | -$3.10M derived: sum of 3 quarters · filed 2024-08-08 | -$3.74M 10-K · filed 2024-02-28 |
| 2023-09-30 | -$2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$2.05M derived: sum of 2 quarters · filed 2024-08-08 | -$2.69M 10-Q · filed 2023-11-01 | -$459.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$579.00K 10-Q · filed 2024-08-08 | $1.65M derived: sum of 3 quarters · filed 2024-08-08 | $1.59M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$636.00K 10-Q · filed 2024-05-01 | $1.59M derived: sum of 2 quarters · filed 2024-05-01 | $1.53M derived: sum of 3 quarters · filed 2024-05-01 | $7.68M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.17M derived: sum of 2 quarters · filed 2024-02-28 | $8.32M derived: sum of 3 quarters · filed 2024-02-28 | $12.71M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $6.09M derived: sum of 2 quarters · filed 2023-11-01 | $10.48M 10-Q · filed 2023-11-01 | $12.57M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $6.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $10.54M 10-Q · filed 2023-08-02 | $12.64M derived: sum of 3 quarters · filed 2024-02-28 | $12.61M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $4.39M 10-Q · filed 2023-05-03 | $6.49M derived: sum of 2 quarters · filed 2024-02-28 | $6.46M derived: sum of 3 quarters · filed 2024-02-28 | $6.43M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.07M derived: sum of 2 quarters · filed 2024-02-28 | $2.04M derived: sum of 3 quarters · filed 2024-02-28 | $3.47M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$52.00K derived: sum of 2 quarters · filed 2022-11-02 | $1.38M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.40M 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $1.43M 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 |